Siili Solutions Plc has completed a secondary offering & a listing transfer to NASDAQ Helsinki
Siili Solutions Plc has completed a 4-times oversubscribed secondary offering and a transfer of the listing to the main market on NASDAQ Helsinki.
Siili Solutions Plc is a listed technology-independent software integrator and digital service partner in Finland. The company offers demanding IT services to various business fields like public sector, banking, media and industry. The primary targets are the Finnish top 500 companies as well as the state and local government.
The main reason for moving from First North marketplace to the main market place was to increase the liquidity of the shares as well as to expand the shareholder base and to support the growth strategy. The company raised US$4 million.
Oaklins' team in Finland advised Siili Solutions and acted as their Certified Advisor on NASDAQ First North Finland. The team also advised them on their groundbreaking IPO in 2012, which was the first IPO in Finland since 2007.


Talk to the deal team
Related deals
BodhiCedric has acquired Network Media from Jellysmack
The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.
Learn moreCustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreDimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn more